NEW YORK (GenomeWeb News) — CollabRx and CellNetix Pathology & Laboratories have signed a multi-year agreement that lets CellNetix make use of CollabRx's technology and content resources in providing sequencing-based testing for oncology.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.
Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.
The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.
The House of Lords in the UK approves a bill to allow mitochondrial donation.